Intralase Files for IPO

Irvine-based Intralase has filed for an IPO to raise up to $92M. Intralase is the developer of the popular LASIK laser surgical vision correction devices and procedure. According to the company's filing with the SEC, Intralase lost $11.9M on revenues of $25.4M in 2003, and has received 7 rounds of funding totaling over $70M. Intralase is backed by Brentwood Associates, Domain Partners, EDF Ventures, InterWest Partners, Meritech Capital, and Versant Ventures. More information »